Laboratory Exercises

 
Complete the even-numbered problems for the designated chapter(s) in the textbook. Students are highly encouraged to complete all problems in each chapter, as odd-numbered problems increase understanding of even-numbered problems (answers to odd numbered problems are located in appendix A at the back of the text.

1.Chapter 4, module 7, exercises 2, 4, and 6
2.Chapter 5, module 9, exercise 2
While APA format is not required for the body of this assignment, solid academic writing is expected and in-text citations and references should be presented using APA documentation guidelines

3
Saving Lives in Saudi Arabia: Reforming a culture of recklessness bravado on the kingdom’s roads
1. Edit the qualitative result chapter based on supervisor comments.
2. Write the Discussion Chapter 10000 words
3. Write the Conclusion Chapter 5000 words
4. I place the order for 20000 words so after we finalize all chapters I want to put them all together this order, the first six chapters and the quantitative results to be one whole thesis

Laboratory Exercises

 
Complete the even-numbered problems for the designated chapter(s) in the textbook. Students are highly encouraged to complete all problems in each chapter, as odd-numbered problems increase understanding of even-numbered problems (answers to odd numbered problems are located in appendix A at the back of the text.
1.Chapter 3, module 5, exercise 2
2.Chapter 3, module 6, exercise 2

While APA format is not required for the body of this assignment, solid academic writing is expected and in-text citations and references should be presented using APA documentation guidelines

History of medical science

 
Focus on the issues of medical power and responsibility. From the industrial roots of the pharmaceutical industry, through imperialism, medicalization, war, human experimentation, and the AIDS epidemic, twentieth century medicine has grappled with some of the most difficult political and ethical issues of the turbulent century just passed. Please write an essay summarizing the main events of long twentieth-century ( meaning 1890s-now) medicine, using the lecture notes and sources provided.
-for the reference
Themes of 20th century primary sources: power, progress, good and evil
1.Origin of the pharmaceutical industry
2.Medicalization
3.Therapeutic Optimism ( optimist, pessimist)
4. Medical Nemesis

*you can use all the lecture notes as sources. Cite as (Lecture 00)
*you can use all the primary sources I gave as much as you want
**You can use other primary sources too but you MUST refer to at least three of the primary sources #5,6,7,8

Pharmacokinetics and Pharmacodynamics

 
Pharmacokinetics and Pharmacodynamics

As an advanced practice nurse assisting physicians in the diagnosis and treatment of disorders, it is important to not only understand the impact of disorders on the body, but also the impact of drug treatments on the body. The relationships between drugs and the body can be described by pharmacokinetics and pharmacodynamics. Pharmacokinetics describes what the body does to the drug through absorption, distribution, metabolism, and excretion, whereas pharmacodynamics describes what the drug does to the body. When selecting drugs and determining dosages for patients, it is essential to consider individual patient factors that might impact the patient’s pharmacokinetic and pharamcodynamic processes. These patient factors include genetics, gender, ethnicity, age, behavior (i.e., diet, nutrition, smoking, alcohol, illicit drug abuse), and/or pathophysiological changes due to disease. In this Discussion, you reflect on a case from your past clinical experiences and consider how a particular patient’s pharmacokinetic and pharmacodynamic processes altered his or her response to a drug.

To prepare:

•Review this week’s media presentation with Dr. Terry Buttaro, as well as Chapter 2 of the Arcangelo and Peterson text, and the Scott article in the Learning Resources. Consider the principles of pharmacokinetics and pharmacodynamics.
•Reflect on your experiences, observations, and/or clinical practices from the last five years. Select a case from the last five years that involves a patient whose individual differences in pharmacokinetic and pharmacodynamic factors altered his or her anticipated response to a drug. When referring to your patient, make sure to use a pseudonym or other false form of identification. This is to ensure the privacy and protection of the patient.
•Consider factors that might have influenced the patient’s pharmacokinetic and pharmacodynamic processes such as genetics (including pharmacogenetics), gender, ethnicity, age, behavior, and/or possible pathophysiological changes due to disease.
•Think about a personalized plan of care based on these influencing factors and patient history in your case study.

Post on or before Day 3 a description of the case you selected. Then, describe factors that might have influenced pharmacokinetic and pharmacodynamic processes of the patient from the case you selected. Finally, explain details of the personalized plan of care that you would develop based on influencing factors and patient history in your case.
RESOURCES:

Readings
•Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
◦Chapter 2, “Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles” (pp. 15–29)

This chapter examines concepts related to pharmacokinetics and pharmacodynamics. It also explores patient factors that health care providers consider when prescribing drug therapy to patients.
◦Chapter 3, “Impact of Drug Interactions and Adverse Events on Therapeutics” (pp. 30–48)

This chapter explains drug-drug, drug-food, drug-herb, and drug-disease interactions. It also reviews patient factors that influence drug interactions and then covers adverse drug reactions.
◦Chapter 4, “Principles of Pharmacotherapy in Pediatrics” (pp. 49–59)

This chapter explores concepts relating to drug selection, administration, and interaction for pediatric patients. It also compares age-related pharmacokinetic differences in children and adults.
◦Chapter 6, “Principles of Pharmacotherapy in Elderly Patients” (pp. 66–78)

This chapter describes issues and factors that affect drug therapy for elderly patients. It then explores concepts relating to drug selection, administration, and management for elderly patients.

•Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007). Clinical pharmacology in the geriatric patient. Fundamental & Clinical Pharmacology, 21(3), 217–230.
Retrieved from the Walden Library databases.

This article explores issues that health care providers consider when prescribing drug treatment to geriatric patients. It also examines the role of polypharmacy in adverse drug reactions and the importance of managing patient response to drug treatment.

•Scott, S. A. (2011). Personalizing medicine with clinical pharmacogenetics. Genetics in Medicine, 13(12), 987–995. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290900/

This article examines pharmacogenetic testing in relation to personalized drug therapy plans and explores evidence-based guidelines and recommendations on pharmacogenetic testing.
•Drugs.com. (2012). Retrieved August 22, 2012, from https://www.drugs.com/

This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.

Media

•Laureate Education, Inc. (Executive Producer). (2012). Introduction to advanced pharmacology. Baltimore, MD: Author.

Note: The approximate length of this media piece is 8 minutes.

In this media presentation, Dr. Terry Buttaro, Associate Professor of Practice at Simmons School of Nursing and Health Sciences, discusses the importance of pharmacology for the advanced practice nurse.

Pharmacology & Toxicology

Complete Parts A (75% of total marks) and B (25% of total marks)
A – Discuss the short-comings of the TGN1412 clinical trial?
B – Summarise the regulatory changes (in particular the EMEA CHMP SWP 2007 guidelines) that were introduced following the TGN1412 incident and explain how then aim to reduce the risks of ‘first-in-man” trials.

Support your discussions with relevant peer-reviewed publications where appropriate and include a list of references.

Guidelines
Word limit is 2000 words (+/- 200 words) in total for Parts A & B combined.
Please include the total word count (excluding references) on the title page.
Example of referencing format below and please note policy on plagiarism.

Referencing:
For this assignment the Vancouver or Harvard style of referencing may be used.

As an example of the Vancouver Style of referencing, the references should be listed in a reference section at the end of the essay (not as footnotes), and should cited by number at the end of the sentence or paragraph to which they relate. Every statement of fact should be supported by a reference. If a whole section is derived from one reference, cite it at the end of the first and last sentence of the relevant section.
Authors, journal details, dates and article titles should all be given. Web sources should be cited giving the URL, the title, the authors, and the date last modified (where possible). The reference list at the end of the assignment should contain all the sources cited, listed numerically according to citation order, and be formatted according to the style shown overleaf.

Medical Statistics

You should read this paper carefully before attempting to answer the following questions. Students are expected to answer all questions in a concise manner and marks will be awarded for clear and succinct answers
1) What type of study design is described here? (2 marks)

2) What type of randomisation has been used? Include details of any stratification if it has been used. (2 marks)

3) Why was the sample size increased after the interim analysis? (3 marks)

4) Using Table 1, what proportion of patients undergoing off-pump CABG had a history of myocardial infarction? (1 mark)

5) The analysis was performed on a modified intention-to-treat basis (ITT) (with all randomly assigned patients who underwent isolated CABG by the assigned surgeon included). Why is ITT preferable in comparison to a per-protocol analysis? (3 marks)

6) Details are given in Figure 1 on the numbers randomised and the numbers excluded after randomisation and at different stages of the trial. Use the information provided to construct a 2×2 table and perform a chi-squared test to evaluate whether there are any differences between allocated groups in the proportions of randomised patients included in the 30-day analysis. (8 marks)

7) Examine Table 1 and answer the following questions
a) How are the logistic euroSCORE and the Koronarchirurgie score summarised? (2 marks)
b) Comment on whether these are appropriate summary statistics to use. (2 marks)
c) What would be an alternative way of summarising these scores (2 marks)

8) The components that make up the primary outcome were measured at 30 days (expressed as an odds ratio using logistic regression) and 12 months (Kaplan-Meier curves and log rank test). What is the primary endpoint and why do you think the authors chose different statistical tests at these time points? (6 marks)

9) Using the results from table 3;
a) What are the odds of repeat revascularization (component of primary outcome) at 30 days for off-pump CABG patients compared to those who received on-pump CABG and how this is interpreted? (3 marks)
b) Was the risk (hazard) of repeat revascularization different at 12 months? Justify your answer (3 marks)

10) Using the Kaplan-Meier curve from figure 2, estimate the proportion of patients in each group that are still event free at 180 days. (3 marks)

 

Final Test

 
Once a society is so organized that medicine can transform people into patients because they are unborn, new born, menopausal, or at some other “age of risk”, the population inevitably loses some of its autonomy to its healers. The ritualization of stages in life is nothing new; what is new is their intense medicalization (Illich, 1979, p.78).
Assess this claim by Illich in relation to the role blockbuster drugs played in medicine during the 20th Century including if there can be any key similarities or differences drawn from the various life cycles of these drugs?

furosemide

 
-draw the structure of drug by using chem draw
-use the BNF, and drug bank website as references.
-i added a sample of the essay but about different drug this student got 70% i would like my essay to be better than hem by adding more. but be careful please i don’t pleasures-um

NUCLEAR MEDICINE PET/MRI

Technologies Assignment
Objective: The student will explain the necessity of continued professional development and lifelong learning for imaging professionals. Furthermore, the student will demonstrate effective written communication skills necessary for imaging professionals.
Purpose: Students will research and analyze an emerging technology or movement in the imaging sciences according following the instructions below. Students will gain a greater appreciation for the scope of the imaging services field including diagnostic, functional, and therapeutic uses. Through these research and writing activities, students will develop effective professional written communication skills as well as an appreciation for the necessity of lifelong learning required to keep abreast of changes and advancement within the profession.
Ideas topics students might consider are:
• CARE Bill/RadCARE bill
• Radiologist Assistants
• Emerging trends in:
o Cardiovascular interventional radiology
o Mammography
o Diagnostic imaging
o Nuclear medicine
o Sonography
o Magnetic resonance imaging (MRI)
o PET/CT
o SPECT/CT
o Computed tomography
o Bone densitometry
o Patient safety/Radiation Safety initiatives
o Quality control/quality assurance
o PACs
o Computer Aided Detection (CAD)
o Education
• Professional development issues:
o Leadership development
o Retention and job satisfaction
o Career advancement
o Continued practice proficiency/Methods for assessing continued competency
• Other topics of student interest will also be considered for approval

Research Paper Instructions
You will write a research paper in full APA formatting on an emerging trend in the imaging sciences of your choosing following the instructions below.
1. Choose an emerging trend for the topic of your research paper.
a. Email your topic to Cathy McGee for approval by 11:59p on Saturday 9/26/15.

2. Once your topic has been approved:
a. You will write a minimum of a four (4) page research paper, not including title and reference pages.
b. Your paper must be written in full APA formatting including running head, title page, abstract, appropriate headings and sub-headings, in-text citations, and reference page.
i. You do not need an Author Note.
ii. You may include images, tables, graphs, etc. to add interest in your paper, but they are not required.
1. Appropriate captions and citations are required for these additions.
iii. A minimum of four sources are required. Only two may be from your textbooks. The remaining sources should come from the PGCC Library research data bases which include peer reviewed journal articles, articles from authoritative newspapers, and magazines. Reliable websites, such as .org or .gov websites may also be used. Wiki’s are not acceptable sources.
iv. A number of APA references and grading rubric have been provided in this unit to assist you.

3. Your paper should at a minimum include:
a. A complete analysis of your emerging technology.
b. Compare & contrast the emerging technology with current imaging modalities or practices.
c. Compare & Contrast the risks and benefits of your emerging technology for the imaging community.
d. Discuss the implications of your new technology for the Radiographer and Radiologist if applicable and the importance of continued professional development.
e. Analyze the impact of your emerging technology for the patient (e.g. improved diagnosis, improved turnaround times, etc.)
4
Topic: I am as an Ethical Leader
PERSONAL LEVEL OF ETHICAL LEADERSHIP.
In this assignment, you work on understanding, analyzing and implementing choices, related to your own ethics-related situations. In doing this, you are expected to demonstrate understanding theoretical foundation of ethical thoughts when you reflect your personal challenges, you apply course frameworks in analyzing your own choices and dilemmas, and you move to the level of defining a direction for personal growth as an ethical leader.

Part 1: YOU as an Ethical Leader
 UNDERSTANDING/AWARENESS: Describe yourself through the prism of psychological approaches (min of three) to ethical leadership
 ANALYZING: Summarize your reflection in personal strengths and weaknesses as an ethical leader. Analyze relevance of these characteristics to the organizational and social environments you plan to work
 IMPLEMENTING: Define a course of action for self-improvement

Part 2: Script for an ethical dilemma you expect to face
 UNDERSTANDING/AWERENESS: Describe an ethical dilemma that you have faced or expect to face in your professional life. What options are possible?
 ANALYZING: Apply two of the prescriptive approaches to analyze each of the options
 IMPLEMENT: Define behavior that you consider as ethical. Define a set of rules and actions that you promise to follow
 REFLECT: Ecology (benefits and risks) of such behavior for you, for the organization, and for the society in large.

Rubrics for grading:
1. Understand (Rigor): Use of conceptual frameworks for self-awareness and reflection in the area of ethical leadership
2. Analyze (Depth & critical thinking): Critical evaluation own choices and actions, revealing strengths and weaknesses/areas for development
3. Implement (Relevance and growth-based): Focus on personal growth as ethical leader. Relevance of the action plan/personal polices for strengthening own ethical leadership capabilities.
4. Presentation: Clarity of writing.